“As we close 2024, I’m proud of the transformative strides we’ve made in advancing software solutions for patient recruitment and remote data collection. From simplifying recruitment workflows with AI-powered tools and streamlining volunteer registries to enhancing patient matching and pre-screening processes for a Top-3 Pharma, our platform has enabled faster, smarter decisions. This year, our software reached new heights—quite literally—by being used by private astronauts on space missions to capture vital health data. We also advanced decentralized trials with virtual visits and real-time analytics, showcasing our commitment to innovation. These achievements reflect the dedication of our team and partners, setting the stage for even greater impact in 2025.”✨❄️
Chintan Patel, CTO, TrialX Inc.
Here’s Wishing You A Very Happy New Year!
🎁 PRODUCT HIGHLIGHTS 2024 🌟
Patient Recruitment Management
- Enabled study teams with AI-powered tools to simplify clinical trial details by country or language.
- Streamlined volunteer registry for quicker follow-up and monitoring of individuals interested in joining clinical trials
- Enhanced our AI based clinical trial finder tool using prompts and patient portal matching
- Supported Top-3 Pharma pre-screening workflow to streamline entire portfolio
- Created the first repository for all participant reported health & wearable data captured on commercial space missions
- Launched antibiotic resistance app for a leading academic institution.
- Enhanced site data capture using virtual visits for fully decentralized or hybrid clinical trials
- Advanced analytics for CROs, sponsors and sites to make informed decisions in real-time
- Complexities of BRCA-Related Breast and Ovarian Cancers with Dr. Katherine L. Nathanson, Penn Medicine – 10K views
- Palliative Care with Dr. Scott Halpern & Dr. Katherine Courtright, Penn Medicine – 2.6K views
- Approaches to Prevent Breast Cancer Recurrence with Dr. Angela DeMichele, Penn Medicine – 3.6K views
EVENTS
🏅 SUCCESS STORIES 🎉
📰 PRESS RELEASES
Our enterprise recruitment platform was selected by the Michael J. Fox Foundation for Parkinson’s Research (MJFF) to power the Fox Trial Finder, a critical tool for the Parkinson’s community to navigate clinical trial information. “Through our partnership with TrialX, Fox Trial Finder connects participants with the right studies for them, speeding trial recruitment & thereby the findings that will drive toward new therapies & better quality of life for the Parkinson’s community.” said Maggie Kuhl, MJFF Vice President of Research Engagement. Read More.
We announced the release of the SAYSTOP Study App for a leading clinical research study investigating antibiotics resistance using TrialX’s remote data collection platform. Investigators at the University of Iowa and UCLA’s Olive View Medical Center, developed this research app to investigate if it is safe for patients to stop their antibiotics when they feel better compared to completing all of their antibiotic pills for urinary tract infections. “Through this collaboration with TrialX, we hope to gather valuable insights into antibiotic usage patterns and ultimately develop strategies to mitigate the spread of antibiotic resistance.” said Brett Faine, the co-principal investigator. Read More.
We announced the launch of our innovative AI based Clinical Trial Finder tool, showcasing a host of features designed to simplify access to clinical trial information for all audiences. Leveraging recent advancements in AI technology, the tool revolutionizes the way users navigate and comprehend complex clinical trial information. Read More.
We are proud to partner with Let’s Win Pancreatic Cancer to launch its innovative global Clinical Trial Finder. This AI-powered tool simplifies access to clinical trials by providing personalized results based on location & health history. With precise searches & bilingual support in English and Spanish, the Trial Finder enhances accessibility and inclusivity for the global pancreatic cancer community. “By partnering with TrialX, we’re ensuring that patients have access to the latest clinical trials in a way that’s simple and actionable.” said Cindy Gavin, CEO and Co-founder of Let’s Win Pancreatic Cancer. Read More.
📈 CONFERENCES
Disruptive innovations in clinical research took center stage at DPHARM 2024 in Philadelphia. Our CTO, Dr. Chintan Patel, and CSO, Paul Donnelly, highlighted how TrialX’s AI-driven platforms are revolutionizing patient recruitment and remote data collection, addressing barriers to participation and promoting diversity in clinical trials. Learn more.
At DIA 2024, we showcased our cutting-edge clinical trial recruitment management and remote data collection platforms, connecting with leaders in biopharma and clinical research. Our unique 🎶“Songs for the Unsung” initiative stole the show, blending innovation with heartfelt engagement. Learn more.
At SCOPE Summit 2024, we explored transformative trends in clinical operations, from AI-driven tools to decentralized trials and inclusive patient recruitment. TrialX’s solutions in remote data collection and diversity outreach sparked meaningful discussions about shaping the future of clinical research both on Earth and in space. Learn more.
Our Co-founder & CEO, Dr. Sharib Khan, attended the NASA IWS 2024 workshop, joining the Translational Research Institute for Space Health (TRISH) and other leading space medicine scientists. At the workshop, there was significant interest in our work on the EXPAND database, developed in collaboration with TRISH. Steve Robinson, former NASA astronaut, remarked, “What you guys are doing, all of us want!”. The EXPAND DB is the first human health & environmental database for commercial space flights, designed to support a variety of data types across a multitude of individual research studies.
🎓 MILESTONE ANNOUNCEMENTS
The Axiom Mission 4 will launch in early spring in 2025 and last up to 14 days! In partnership with TRISH (The Translational Research Institute for Space Health) we are excited to support yet another space mission through the EXPAND App that collects and stores pre-flight, in-flight and post-flight health data from commercial astronauts during space missions. TRISH will conduct a suite of human health and performance research projects during this misson that includes crew members from India, Poland, and Hungary, marking each nation’s first mission to the international space station in history. Stay tuned for more! ✨
Photo credit: Axiom Space
We are honored to have been chosen to power the clinical trial finder for the ground breaking Reflections initiative which aims to enhance diversity in clinical trials and increase clinical trials awareness at the grass roots level using art. This initiative drives visitors to the website www.BeReflected.org, where they can explore multiple resources to support their journey to trial participation.
In collaboration with the Translational Research Institute for Space Health (TRISH), we are proud to be one of the partners in the Polaris Dawn Mission – a commercial spaceflight endeavor. Our team played a pivotal role in developing the EXPAND app which ensured seamless pre-flight, in-flight and post-flight health research data collection, management and analysis. This milestone mission pushed the boundaries of space exploration with the first-ever private spacewalk and reach the highest altitude since Apollo 17. We supported this bold mission, taking decentralized clinical research data collection to the extreme edge where no humans have gone in the last 50 years. Learn more about our remote data collection platform.
Our innovative work in the field of space health research was prominently featured as – not one, but two groundbreaking papers – in Nature. These papers focus on decentralized research in space missions & the significant impacts of space travel on human health, showcasing data collected using our cutting-edge technology platform. We are proud to have been the technology partner selected to collect, manage & analyze this invaluable data.
✌ TEAM UPDATES 🎂
🎉Celebrating 16 Years of Innovation at TrialX!
✨ LOOKING FORWARD TO 2025 🌅
- 🔮 The Future of Clinical Trials: Four Key Trends to Watch in 2025
- 💯 Abbvie’s recent success with the late-stage TEMPO-2 trial for Parkinson’s disease treatment sets stage for an eventful 2025
- 🧑🚀️ Humans could ‘inject nanoparticles’ to survive deadly deep-space cancer on trips to Elon Musk’s Mars colony
- 🚀 Space exploration with NASA: Where will space research take us in 2025?
Team TrialX,
TrialX.com
